BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 3742248)

  • 1. Analysis of the avoidance learning deficit induced by the serotonin releasing compound p-chloroamphetamine.
    Ogren SO
    Brain Res Bull; 1986 May; 16(5):645-60. PubMed ID: 3742248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forebrain serotonin and avoidance learning: behavioural and biochemical studies on the acute effect of p-chloroamphetamine on one-way active avoidance learning in the male rat.
    Ogren SO
    Pharmacol Biochem Behav; 1982 Jun; 16(6):881-95. PubMed ID: 7111347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a role of brain serotonergic neurotransmission in avoidance learning.
    Ogren SO
    Acta Physiol Scand Suppl; 1985; 544():1-71. PubMed ID: 3006431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of the associative and non-associative effects of brain serotonin released by p-chloroamphetamine: dissociable serotoninergic involvement in avoidance learning, pain and motor function.
    Ogren SO; Johansson C
    Psychopharmacology (Berl); 1985; 86(1-2):12-26. PubMed ID: 3927348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and fear retention in the rat.
    Archer T
    J Comp Physiol Psychol; 1982 Jun; 96(3):491-516. PubMed ID: 7096685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive serotonin release, not depletion, leads to memory impairments in rats.
    Santucci AC; Knott PJ; Haroutunian V
    Eur J Pharmacol; 1996 Jan; 295(1):7-17. PubMed ID: 8925877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central serotonin neurones in avoidance learning: interactions with noradrenaline and dopamine neurones.
    Ogren SO
    Pharmacol Biochem Behav; 1985 Jul; 23(1):107-23. PubMed ID: 2994116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acute effect of p-chloroamphetamine on the retention of fear conditioning in the rat: evidence for a role of serotonin in memory consolidation.
    Archer T; Ogren SO; Johansson C
    Neurosci Lett; 1981 Aug; 25(1):75-81. PubMed ID: 7279303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition and retention of enhanced active avoidance are unaffected by interference with serotonergic activity.
    Galindo LE; Garín-Aguilar ME; Medina AC; Serafín N; Quirarte GL; Prado-Alcalá RA
    Behav Brain Res; 2008 Dec; 195(1):153-8. PubMed ID: 18342379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin involvement in aversive conditioning: reversal of the fear retention deficit by long-term p-chloroamphetamine but not p-chlorophenylalanine.
    Archer T; Ogren SO; Ross SB
    Neurosci Lett; 1982 Dec; 34(1):75-82. PubMed ID: 6219302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptamine and learning: long-term effects of P-chloroamphetamine on acquisition.
    Ogren S; Ross SB; Baumann L
    Med Biol; 1975 Jun; 53(3):165-8. PubMed ID: 1160410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active and passive avoidance following the administration of systemic DSP4, xylamine, or p-chloroamphetamine.
    Archer T; Jonsson G; Ross SB
    Behav Neural Biol; 1985 May; 43(3):238-49. PubMed ID: 3842248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scopolamine amnesia of passive avoidance: a deficit of information acquisition.
    Rush DK
    Behav Neural Biol; 1988 Nov; 50(3):255-74. PubMed ID: 3202811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin receptor involvement in the avoidance learning deficit caused by p-chloroamphetamine-induced serotonin release.
    Ogren SO
    Acta Physiol Scand; 1986 Mar; 126(3):449-62. PubMed ID: 2870606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buspirone impaired acquisition and retention in avoidance tasks: involvement of the hippocampus.
    Liang KC; Tsui KY; Tyan YM; Chiang TC
    Chin J Physiol; 1998; 41(1):33-44. PubMed ID: 9629480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pretraining intrastriatal administration of p-chloroamphetamine on inhibitory avoidance.
    Solana-Figueroa R; Salado-Castillo R; Galindo LE; Quirarte GL; Prado-Alcalá RA
    Neurobiol Learn Mem; 2002 Jul; 78(1):178-85. PubMed ID: 12071674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitation of avoidance acquisition in rats produced by P-chlorophenylalanine or P-chloroamphetamine.
    Vorhees CV
    Pharmacol Biochem Behav; 1979 Apr; 10(4):569-76. PubMed ID: 156926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention deficits induced by acute p-chloroamphetamine following fear conditioning in the rat.
    Archer T; Ogren SO; Ross SB; Magnusson O
    Psychopharmacology (Berl); 1984; 82(1-2):14-9. PubMed ID: 6229804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of serotonin using p-chlorophenylalanine (PCPA) and reserpine protects against the neurotoxic effects of p-chloroamphetamine (PCA) in the brain.
    Berger UV; Grzanna R; Molliver ME
    Exp Neurol; 1989 Feb; 103(2):111-5. PubMed ID: 2521470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.